Clinical Trial

An Open-Label, Double-Treatment Group Study to Evaluate the Efficacy and Safety of Human Allogeneic Bone-Marrow- Derived Mesenchymal Stromal Cell Product StromaForte Compared With Hyaluronic Acid for the Treatment of Knee Osteoarthritis

Name: An Open-Label, Double-Treatment Group Study to Evaluate the Efficacy and Safety of Human Allogeneic Bone-Marrow- Derived Mesenchymal Stromal Cell Product StromaForte Compared With Hyaluronic Acid for the Treatment of Knee Osteoarthritis — clinical trial record (NCT07542808)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2/3

View on ClinicalTrials.gov →

Summary

StromaForte injection for knee OA

Trial Details

NCT Number	NCT07542808
Lead Sponsor	Cellcolabs Clinical SPV Limited
Conditions	Knee Arthritis Osteoarthritis
Enrollment	140 participants
Start Date	2026-04-27
Primary Completion	2027-09-27 (estimated)
Study Completion	2027-09-27 (estimated)
Updated on ClinicalTrials.gov	2026-04-21